NKp46-specific single domain antibodies enable facile engineering of various potent NK cell engager formats

被引:15
作者
Lipinski, Britta [1 ,2 ]
Arras, Paul [1 ]
Pekar, Lukas [1 ]
Klewinghaus, Daniel [1 ]
Boje, Ammelie Svea [3 ,4 ]
Krah, Simon [1 ]
Zimmermann, Jasmin [1 ,2 ]
Klausz, Katja [3 ,4 ]
Peipp, Matthias [3 ,4 ]
Siegmund, Vanessa [5 ]
Evers, Andreas [6 ]
Zielonka, Stefan [1 ,2 ,7 ]
机构
[1] Merck Healthcare KGaA, Prot Engn & Antibody Technol, Darmstadt, Germany
[2] Tech Univ Darmstadt, Inst Organ Chem & Biochem, Darmstadt, Germany
[3] Univ Hosp Schleswig Holstein, Dept Internal Med 2, Div Antibody Based Immunotherapy, Kiel, Germany
[4] Christian Albrechts Univ Kiel, Kiel, Germany
[5] Merck Healthcare KGaA, Prot & Cell Sci, Darmstadt, Germany
[6] Merck Healthcare KGaA, Computat Chem & Biol, Darmstadt, Germany
[7] Merck Healthcare KGaA, Prot Engn & Antibody Technol, Frankfurter Str 250, D-64293 Darmstadt, Germany
关键词
ADCC; antibody engineering; bispecific antibody; multifunctional antibody; NK cell engager; NK cell redirection; NKp46; single domain antibody; valencies; VHH; FC-GAMMA-RIIA; MELANOMA-CELLS; RECEPTOR; NKP30; LIGAND; EGFR; POLYMORPHISMS; CYTOTOXICITY; IMPACT;
D O I
10.1002/pro.4593
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Herein, we describe the generation of potent NK cell engagers (NKCEs) based on single domain antibodies (sdAbs) specific for NKp46 harboring the humanized Fab version of Cetuximab for tumor targeting. After immunization of camelids, a plethora of different VHH domains were retrieved by yeast surface display. Upon reformatting into Fc effector-silenced NKCEs targeting NKp46 and EGFR in a strictly monovalent fashion, the resulting bispecific antibodies elicited potent NK cell-mediated killing of EGFR-overexpressing tumor cells with potencies (EC(50)killing) in the picomolar range. This was further augmented via co-engagement of Fc gamma receptor IIIa (Fc gamma RIIIa). Importantly, NKp46-specific sdAbs enabled the construction of various NKCE formats with different geometries and valencies which displayed favorable biophysical and biochemical properties without further optimization. By this means, killing capacities were further improved significantly. Hence, NKp46-specific sdAbs are versatile building blocks for the construction of different NKCE formats.
引用
收藏
页数:16
相关论文
共 62 条
[31]   Grabbing the Bull by Both Horns: Bovine Ultralong CDR-H3 Paratopes Enable Engineering of 'Almost Natural' Common Light Chain Bispecific Antibodies Suitable For Effector Cell Redirection [J].
Klewinghaus, Daniel ;
Pekar, Lukas ;
Arras, Paul ;
Krah, Simon ;
Valldorf, Bernhard ;
Kolmar, Harald ;
Zielonka, Stefan .
FRONTIERS IN IMMUNOLOGY, 2022, 12
[32]   Recombinant Antibodies to Arm Cytotoxic Lymphocytes in Cancer Immunotherapy [J].
Koch, Joachim ;
Tesar, Michael .
TRANSFUSION MEDICINE AND HEMOTHERAPY, 2017, 44 (05) :337-350
[33]   Camelid and shark single domain antibodies: structural features and therapeutic potential [J].
Koenning, Doreen ;
Zielonka', Stefan ;
Grzeschik, Julius ;
Empting, Martin ;
Valldorfl, Bernhard ;
Krah, Simon ;
Schroeter, Christian ;
Sellmann, Carolin ;
Hock, Bjoern ;
Kolmarl, Harald .
CURRENT OPINION IN STRUCTURAL BIOLOGY, 2017, 45 :10-16
[34]   Engineering IgG-Like Bispecific AntibodiesAn Overview [J].
Krah, Simon ;
Kolmar, Harald ;
Becker, Stefan ;
Zielonka, Stefan .
ANTIBODIES, 2018, 7 (03)
[35]   Engineering bispecific antibodies with defined chain pairing [J].
Krah, Simon ;
Sellmann, Carolin ;
Rhiel, Laura ;
Schroeter, Christian ;
Dickgiesser, Stephan ;
Beck, Jan ;
Zielonka, Stefan ;
Toleikis, Lars ;
Hock, Bjoern ;
Kolmar, Harald ;
Becker, Stefan .
NEW BIOTECHNOLOGY, 2017, 39 :167-173
[36]   Single-domain antibodies for biomedical applications [J].
Krah, Simon ;
Schroeter, Christian ;
Zielonka, Stefan ;
Empting, Martin ;
Valldorf, Bernhard ;
Kolmar, Harald .
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY, 2016, 38 (01) :21-28
[37]   Bispecific antibodies: a mechanistic review of the pipeline [J].
Labrijn, Aran F. ;
Janmaat, Maarten L. ;
Reichert, Janice M. ;
Parren, Paul W. H. I. .
NATURE REVIEWS DRUG DISCOVERY, 2019, 18 (08) :585-608
[38]   NK Cell Recognition and Killing of Melanoma Cells Is Controlled by Multiple Activating Receptor-Ligand Interactions [J].
Morgado, Sara ;
Sanchez-Corre, Beatriz ;
Casado, Javier G. ;
Duran, Esther ;
Gayoso, Inmaculada ;
Labella, Fernando ;
Solana, Rafael ;
Tarazona, Raquel .
JOURNAL OF INNATE IMMUNITY, 2011, 3 (04) :365-373
[39]   A general protocol for the generation of Nanobodies for structural biology [J].
Pardon, Els ;
Laeremans, Toon ;
Triest, Sarah ;
Rasmussen, Soren G. F. ;
Wohlkoenig, Alexandre ;
Ruf, Armin ;
Muyldermans, Serge ;
Hol, Wim G. J. ;
Kobilka, Brian K. ;
Steyaert, Jan .
NATURE PROTOCOLS, 2014, 9 (03) :674-693
[40]   Immunotherapeutic targeting of activating natural killer cell receptors and their ligands in cancer [J].
Peipp, Matthias ;
Klausz, Katja ;
Boje, Ammelie Svea ;
Zeller, Tobias ;
Zielonka, Stefan ;
Kellner, Christian .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2022, 209 (01) :22-32